Clinical Trials Browser

Phase 2 × Surveys and Questionnaires × Tumor-Agnostic × Clear all

NCT00353145 2012-08-02

Gemox as First and Second Line Therapy in Unknown Primary Cancer

Phase 2 Completed

Neoplasms, Unknown Primary